Sulfasalazine (SSZ), which has been identified as an SPR inhibitor, could inhibit the growth of NB cells and produce synergistic antiproliferative effects in combination with alpha‐difluoromethylornithine.103. The gene discussed is SPR; the disease is neuroblastoma.